Hybrid Imaging Market - Technavio Announces Top Three Market Drivers

Technavio has published a new report on the global hybrid imaging market from 2017-2021.(Graphic: Business Wire)

???pagination.previous??? ???pagination.next???

LONDON--()--Technavio analysts forecast the global hybrid imaging market to grow at a CAGR of 8% during the forecast period, according to their latest report.

The research study covers the present scenario and growth prospects of the global hybrid imaging market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various hybrid imaging systems to key end-users, such as hospitals, diagnostic centers, and ambulatory centers.

The growing demand for diagnosing chronic conditions such as Alzheimer's disease, cancer, and other neurological conditions increases the demand for hybrid imaging. According to CDC estimates in 2013 report updates, 5 million people in the Americas have Alzheimer's disease, and it also estimated that the number is expected to reach to 14 million by 2050. Also, increased awareness among individuals about the advantages of hybrid imaging as compared with individual imaging techniques increases the demand for hybrid imaging.

Request a sample report: http://www.technavio.com/request-a-sample?report=56800

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Technavio healthcare and life sciences analysts highlight the following three factors that are contributing to the growth of the global hybrid imaging market:

Increasing prevalence of chronic disorders

The increased prevalence of chronic disorders heightens the demand for diagnostic devices. The diagnosis of chronic disorders with hybrid imaging systems is gaining wide acceptance due to its accuracy diagnosis and less diagnosis time. For instance, the incidence of lung cancer is the highest in Europe. In 2014, Hungary had the highest incidence of lung cancer, amounting to approximately 54.26 cases per 100,000 individuals.

Barath Palada, a lead medical imaging analyst at Technavio, says, “Hybrid imaging system scans have become essential diagnostic techniques for diagnosing and treating cancer, as these techniques help physicians evaluate the extent of a disease, determine if the treatment is working, and help detect recurrent tumors.”

Growing adoption of PET/CT hybrid imaging

The market witnesses a growing adoption of PET/CT hybrid imaging technology, owing to its advantages such as early diagnosis, accurate disease staging, and effective response to the treatment of chronic conditions such as cancer. The combined PET/CT scans provide images that pinpoint the anatomic location of metabolic activity of an individual.

PET/CT is the gold standard for oncology imaging, and vendors are improving the technological capabilities of PET/CT hybrid imaging system. This will further improve the adoption rates worldwide,” adds Barath.

Limitations involved in individual imaging systems

The limitations associated with the use of individual imaging systems is expected to drive the adoption of hybrid imaging systems. For instance, CT has been the gold standard in oncologic imaging for the past 20 years. However, the technique lacks the ability to show critical differences in physiology.

PET is also one of the established imaging techniques to determine the metabolic activity of tissues but requires the assistance from other systems to produce higher-resolution images. Therefore, vendors have focused on integrating the PET and CT systems and improving the diagnostic accuracy and localization of tumors to provide better-integrated data.

Top vendors:

  • GE Healthcare
  • Mediso
  • Siemens Healthcare
  • Philips Medical Systems

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like oncology, vaccines, and urology devices. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

Technavio analysts forecast the global hybrid imaging market to grow at a CAGR of 8% during the forecast period, according to their latest report.

$Cashtags

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com